ConductScience.org, home

Paper31350853

Using Electronic Health Records to Derive Control Arms for Early Phase Single-Arm Lung Cancer Trials: Proof-of-Concept in Randomized Controlled Trials.

Carrigan G and 8 others. Clin Pharmacol Ther, 2020. Cited by 85 papers, by iCite.

Cite this record

ConductScience Library. Using Electronic Health Records to Derive Control Arms for Early Phase Single-Arm Lung Cancer Trials: Proof-of-Concept in Randomized Controlled Trials. Papers, record 31350853. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31350853

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Using Electronic Health Records to Derive Control Arms for Early Phase Single-Arm Lung Cancer Trials: Proof-of-Concept in Randomized Controlled Trials.
PubMed
Journal
Clin Pharmacol Ther
PubMed
Year
2020
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
85
iCite
Relative citation ratio, by iCite
3.69
iCite
Revised in PubMed
2024-03-28
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Carrigan GGillis
2Whipple SSamuel
3Capra WBWilliam B
4Taylor MDMichael D
5Brown JSJeffrey S
6Lu MMichael
7Arnieri BBrandon
8Copping RRyan
9Rothman KJKenneth J

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Non-Small-Cell LungMajor topic
Databases, FactualMajor topic
Electronic Health RecordsMajor topic
Lung NeoplasmsMajor topic
Research DesignMajor topic
Humans
Proportional Hazards Models
Survival Analysis
United States

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in32542679Externally Controlled Trials: Are We There Yet?https://conductscience.org/library/papers/32542679

Source PubMed

Download CSV of comments and corrections

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124465467Generation of "virtual" control groups for single arm prostate cancer adjuvant trials.PLoS One2014https://conductscience.org/library/papers/24465467PubMed
222207554High MET copy number and MET overexpression: poor outcome in non-small cell lung cancer patients.Histol Histopathol2012https://conductscience.org/library/papers/22207554PubMed
330673081Modernizing Clinical Trials for Patients With Cancer.JAMA2019https://conductscience.org/library/papers/30673081PubMed
427650716"Threshold-crossing": A Useful Way to Establish the Counterfactual in Clinical Trials?Clin Pharmacol Ther2016https://conductscience.org/library/papers/27650716PubMed
528715550Multidimensional Evidence Generation and FDA Regulatory Decision Making: Defining and Using "Real-World" Data.JAMA2017https://conductscience.org/library/papers/28715550PubMed
629756355Development and Validation of a High-Quality Composite Real-World Mortality Endpoint.Health Serv Res2018https://conductscience.org/library/papers/29756355PubMed
728182270Use of External Controls in Regulatory Decision-Making.Clin Pharmacol Ther2017https://conductscience.org/library/papers/28182270PubMed
88957065Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivo and its prognostic significance.Jpn J Cancer Res1996https://conductscience.org/library/papers/8957065PubMed
929059439Real-world Data for Clinical Evidence Generation in Oncology.J Natl Cancer Inst2017https://conductscience.org/library/papers/29059439PubMed
1019767093Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study.Lancet2009https://conductscience.org/library/papers/19767093PubMed
1119255323Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients.J Clin Oncol2009https://conductscience.org/library/papers/19255323PubMed
1227363818Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999-2014.BMJ Open2016https://conductscience.org/library/papers/27363818PubMed
1329881734A Data Quality Assessment Guideline for Electronic Health Record Data Reuse.EGEMS (Wash DC)2017https://conductscience.org/library/papers/29881734PubMed
1427288979Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK-Targeted Therapies in Previously Treated Advanced NSCLC: An Adjusted Comparison with External Controls.J Thorac Oncol2016https://conductscience.org/library/papers/27288979PubMed
1527096309Opportunities and challenges in leveraging electronic health record data in oncology.Future Oncol2016https://conductscience.org/library/papers/27096309PubMed
1628232724Regulatory watch: From big data to smart data: FDA's INFORMED initiative.Nat Rev Drug Discov2017https://conductscience.org/library/papers/28232724PubMed
1729944008Comparative effectiveness from a single-arm trial and real-world data: alectinib versus ceritinib.J Comp Eff Res2018https://conductscience.org/library/papers/29944008PubMed
1818506025Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.J Clin Oncol2008https://conductscience.org/library/papers/18506025PubMed
1930873729An evaluation of the impact of missing deaths on overall survival analyses of advanced non-small cell lung cancer patients conducted in an electronic health records database.Pharmacoepidemiol Drug Saf2019https://conductscience.org/library/papers/30873729PubMed
2021079147
Phase III trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer: results of a west Japan oncology group study.
J Clin Oncol2010https://conductscience.org/library/papers/21079147PubMed

See all 21 referencesDownload CSV of references

Cited by52

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 85 citations.

PMIDTitleJournalYearIn PapersSource
42704204Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma.Clin Pharmacol Ther2026https://conductscience.org/library/papers/42704204PubMed
42415230Comparison of epcoritamab, lenalidomide, and rituximab versus usual care in relapsed/refractory follicular lymphoma.Oncoimmunology2026https://conductscience.org/library/papers/42415230PubMed
42368718Testing for treatment effect twice using internal and external controls in clinical trials.J Causal Inference2023https://conductscience.org/library/papers/42368718PubMed
42277552Real-World Evidence of Treatment Patterns, Time to Real-World Progression, and Overall Survival of Patients With Testicular Germ Cell Tumors Receiving Palliative Chemotherapy in the United States.Cancer Med2026https://conductscience.org/library/papers/42277552PubMed
42164498Biomarkers for predicting immunotherapy response and resistance in glioblastoma.Front Immunol2026https://conductscience.org/library/papers/42164498PubMed
41635962Sieving for gold: external comparator studies to prioritize drugs for late-stage clinical trial.J Comp Eff Res2026https://conductscience.org/library/papers/41635962PubMed
40979394Application of the target trial emulation framework to external comparator studies.Front Drug Saf Regul2024https://conductscience.org/library/papers/40979394PubMed
40442865Examining the Reliability of Model-Based Meta-Analysis (MBMA) Outcomes: A Simulation Study.CPT Pharmacometrics Syst Pharmacol2026https://conductscience.org/library/papers/40442865PubMed
40419286Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patients.Br J Haematol2026https://conductscience.org/library/papers/40419286PubMed
40377841An External Control Arm for the Oral Factor XIa Inhibitor Asundexian Phase 2 Trial in Atrial Fibrillation (PACIFIC-AF) Using Electronic Health Records.Cardiol Ther2025https://conductscience.org/library/papers/40377841PubMed
40199298Clinical Research Informatics: a Decade-in-Review.Yearb Med Inform2024https://conductscience.org/library/papers/40199298PubMed
40136297Quantitative Bias Analysis for Single-Arm Trials With External Control Arms.JAMA Netw Open2025https://conductscience.org/library/papers/40136297PubMed
39514601A causal inference framework for leveraging external controls in hybrid trials.Biometrics2024https://conductscience.org/library/papers/39514601PubMed
39487399Incorporating external controls in the design of randomized clinical trials: a case study in solid tumors.BMC Med Res Methodol2024https://conductscience.org/library/papers/39487399PubMed
39285061A Framework for the Use and Likelihood of Regulatory Acceptance of Single-Arm Trials.Ther Innov Regul Sci2024https://conductscience.org/library/papers/39285061PubMed
39102176Examining the Effect of Missing Data and Unmeasured Confounding on External Comparator Studies: Case Studies and Simulations.Drug Saf2024https://conductscience.org/library/papers/39102176PubMed
39073872Optimizing Clinical Trial Eligibility Design Using Natural Language Processing Models and Real-World Data: Algorithm Development and Validation.JMIR AI2024https://conductscience.org/library/papers/39073872PubMed
38984669Examining external control arms in oncology: A scoping review of applications to date.Cancer Med2024https://conductscience.org/library/papers/38984669PubMed
38965433Harnessing EHR data for health research.Nat Med2024https://conductscience.org/library/papers/38965433PubMed
38785683Comparing prospectively assigned trial and real-world lung cancer patients.J Comp Eff Res2024https://conductscience.org/library/papers/38785683PubMed

See all 52 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
HGF3082PubTator's text mininghttps://conductscience.org/library/genes/3082NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31350853

GET https://conductscience.org/api/papers/v1/31350853/references?page=2